Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

Stock markets mostly fell, the dollar slid and and gold hit a record high Wednesday over fears about a trade war between ...

The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...

The company said, “By 2031, GSK (GSK) now expects to achieve sales of more than GBP 40B, previously greater than GBP 38B, on a risk-adjusted ...

Q4 2024 dividend of 16p declared; 61p FY 2024; 64p expected for 2025. GSK (GSK) now intends to commence a GBP 2B share buyback programme, to be ...

GSK has reported a 7% increase in full-year revenue for 2024, reaching £31.4 billion ($39.3 billion), slightly surpassing market expectations. The fourth quarter contributed £8.1 billion, a 4% rise ...